| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 16 |
| 1 | ETANERCEPT | 16 |
| 2 | LEFLUNOMIDE | 13 |
| 3 | METHOTREXATE SODIUM | 13 |
| 4 | ABATACEPT | 12 |
| 5 | ACETAMINOPHEN | 12 |
| 6 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 12 |
| 7 | METHOTREXATE | 12 |
| 8 | SULFASALAZINE | 12 |
| 9 | HYDROXYCHLOROQUINE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS | 2 | 0.0053 |
| 1 | VUTRISIRAN | 1 | 0.0003 |
| 2 | FLUVASTATIN SODIUM | 1 | 0.0002 |
| 3 | SULFASALAZINE | 12 | 0.0002 |
| 4 | TRIAMTERENE | 1 | 0.0001 |
| 5 | LEFLUNOMIDE | 13 | 0.0001 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 7 | SIPONIMOD | 1 | 0.0001 |
| 8 | ABATACEPT | 12 | 0.0001 |
| 9 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 12 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 17 |
| 1 | Aminosalicylate [EPC] | 13 |
| 2 | Antirheumatic Agent [EPC] | 13 |
| 3 | Expectorant [EPC] | 12 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 12 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 12 |
| 6 | Corticosteroid [EPC] | 7 |
| 7 | Interferon beta [EPC] | 6 |
| 8 | Potassium Channel Blocker [EPC] | 4 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Aminosalicylate [EPC] | 13 | 0.0001 |
| 2 | Antirheumatic Agent [EPC] | 13 | 0.0001 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 12 | 0.0001 |
| 4 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 5 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 6 | Expectorant [EPC] | 12 | 0.0001 |
| 7 | Potassium Channel Blocker [EPC] | 4 | 0.0001 |
| 8 | Pyrimidine Synthesis Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |